⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
globenewswire.com
NVS
MRK
ARGX
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
globenewswire.com
NVS
MRK
ARGX
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
globenewswire.com
NVS
Pharmaceuticals, Biotechnology and Diagnostics M&A Agreements Report/Directory 2026: Analyse 2,500+ Deals Signed Since 2021 - Company A-Z, Therapeutic Area, Technology Type, and Industry Segment
globenewswire.com
JNJ
NVS
Pharmaceuticals, Biotechnology and Diagnostics M&A Agreements Report/Directory 2026: Analyse 2,500+ Deals Signed Since 2021 - Company A-Z, Therapeutic Area, Technology Type, and Industry Segment
globenewswire.com
JNJ
NVS
Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight USA - English USA - español USA - Deutsch
prnewswire.com
NVS
LLY
AZN
Novo Holdings announces 2025 Annual Results
globenewswire.com
NVO
NVS
EVTC
Ipsen appoints Michelle C. Werner as EVP, President of North America
globenewswire.com
BMY
AZN
NVS
Ipsen appoints Michelle C. Werner as EVP, President of North America
globenewswire.com
BMY
AZN
NVS
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
prnewswire.com
GILD
INCY
BIIB
NVS
AMGN
JNJ
ABBV
BMY
AZN
MRK
PFE
TGTX
XNCR
CABA
IMUX
ZNTL
GLPG
CLNN
AUTL